6321-0212 Screening compound: 7-(3,4-dimethoxyphenyl)-5-(4-ethoxyphenyl)-4H,5H,6H,7H-[1,2,4]triazolo[1,5-a]pyrimidine

6321-0212 Screening compound: 7-(3,4-dimethoxyphenyl)-5-(4-ethoxyphenyl)-4H,5H,6H,7H-[1,2,4]triazolo[1,5-a]pyrimidine
6321-0212 Screening compound: 7-(3,4-dimethoxyphenyl)-5-(4-ethoxyphenyl)-4H,5H,6H,7H-[1,2,4]triazolo[1,5-a]pyrimidine alternative view

Chemical Structure Depiction of ChemDiv screening compound 6321-0212
7-(3,4-dimethoxyphenyl)-5-(4-ethoxyphenyl)-4H,5H,6H,7H-[1,2,4]triazolo[1,5-a]pyrimidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6321-0212

Molecular Formula

C21H24N4O3 (C21 H24 N4 O3)

Compound Name

7-(3,4-dimethoxyphenyl)-5-(4-ethoxyphenyl)-4H,5H,6H,7H-[1,2,4]triazolo[1,5-a]pyrimidine

IUPAC name

(5S7R)-7-(34-dimethoxyphenyl)-5-(4-ethoxyphenyl)-4H5H6H7H-[124]triazolo[15-a]pyrimidine

SMILES

CCOc1ccc([C@@H](C2)Nc3ncnn3[C@@H]2c(cc2)cc(OC)c2OC)cc1

InChI

InChI=1S/C21H24N4O3/c1-4-28-16-8-5-14(6-9-16)17-12-18(25-21(24-17)22-13-23-25)15-7-10-19(26-2)20(11-15)27-3/h5-11,13,17-18H,4,12H2,1-3H3,(H,22,23,24)/t17-,18-/m1/s1

InChI Key

HHFWTJCXXSPCBI-QZTJIDSGSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.45

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.438

Distribution Coefficient, logD

3.438

Water Solubility, LogSw

-3.54

Polar Surface Area

61.453

Acid Dissociation Constant (pKa)

15.42

Base Dissociation Constant (pKb)

3.72

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

33.33

6321-0212 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral HBV Library (10007 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with 6321-0212 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6321-0212?
Check Price and Availability of 6321-0212, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6321-0212 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6321-0212
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6321-0212
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6321-0212 available by request